Literature DB >> 18443555

Novel PRNP mutation in a patient with a slow progressive dementia syndrome.

Uta Heinemann1, Anna Krasnianski, Bettina Meissner, Eva M Grasbon-Frodl, Hans A Kretzschmar, Inga Zerr.   

Abstract

BACKGROUND: Creutzfeldt-Jakob disease is a rare neurodegenerative disorder with a worldwide incidence of 1.5 per million inhabitants. About 10-15% of all cases of Creutzfeldt-Jakob disease are of genetic origin and display a large variety in clinical presentation (regarding disease duration, age at onset, and others). The goal of this report was to describe the clinical features and diagnostic tests in a patient with a novel prion protein gene (PRNP) D202G mutation. CASE REPORT: A 71-year-old patient had all the clinical signs of Creutzfeldt-Jakob disease (CJD) but an extremely prolonged disease duration of 16 years. The 14-3-3 protein test was positive, while MRI and EEG did not show CJD typical changes. Family history was positive for cerebellar and dementia disorders without definite diagnoses. Full-length sequencing of the prion protein gene (PRNP) showed a new D202G mutation associated with valine on codon 129 of unknown significance. Methionine/valine heterozygosity at codon 129 was found.
CONCLUSIONS: These findings highlight the value of 14-3-3 and gene analysis in unclear neurological disorders to detect possibly atypical presentations of prion disorders. The significance of this new mutation will remain unclear until further such patients are reported.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443555

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  8 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

3.  A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes.

Authors:  Mercedes Muñoz-Nieto; Neus Ramonet; Juan Ignacio López-Gastón; Natividad Cuadrado-Corrales; Olga Calero; Marcos Díaz-Hurtado; José Ramón Ipiens; Santiago Ramón y Cajal; Jesús de Pedro-Cuesta; Miguel Calero
Journal:  J Neurol       Date:  2012-07-05       Impact factor: 4.849

Review 4.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

5.  Familial Creutzfeldt-Jakob disease with V180I mutation.

Authors:  Tae-Il Yang; Dae-Soo Jung; Bo-Young Ahn; Byung-Hoon Jeong; Han-Jeong Cho; Yong-Sun Kim; Duk L Na; Michael D Geschwind; Eun-Joo Kim
Journal:  J Korean Med Sci       Date:  2010-06-16       Impact factor: 2.153

6.  Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.

Authors:  Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; Enrique Alcalde-Cabero; Fernando José García López; Javier Almazán-Isla; María Ruiz-Tovar; Maria-José Medrano; Fuencisla Avellanal; Olga Calero; Miguel Calero
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

7.  Mutational analysis of PRNP in Alzheimer's disease and frontotemporal dementia in China.

Authors:  Weiwei Zhang; Bin Jiao; Tingting Xiao; Chuzheng Pan; Xixi Liu; Lin Zhou; Beisha Tang; Lu Shen
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

8.  Early-onset Alzheimer's disease patient with prion (PRNP) p.Val180Ile mutation.

Authors:  Eva Bagyinszky; Min Ju Kang; Jungmin Pyun; Vo Van Giau; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-16       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.